Market by Type, Application, End-users, and Country Outlook | Forecast 2022-2028
According to Triton’s
research report, the amniotic membrane market in North America is anticipated
to witness revenue growth at a CAGR of
6.82% during the forecasting years from 2022 to 2028.
Report scope can be customized per your requirements. Request For Customization
The
countries considered in the region are:
•
The United States
•
Canada
The
United States holds the highest market share in the North American amniotic
membrane market. The
amniotic membrane demand has grown considerably over the years, owing to the
rising advanced techniques to cure injuries. Moreover, the surge in research
activities has encouraged several institutes to develop better preserved
amniotic membrane for longer applications. Furthermore, the presence of notable
players such as Amnio Technology LLC, Katena Products Inc, and Surgilogix LLC
supports the amniotic membrane market’s development on a large scale.
In the United States, the application of
amniotic membrane is growing significantly, especially in ocular surface
disorders. Moreover, it has been used in limbal transplantation. The amniotic
membrane plays a crucial role in providing support and protection to
transplanted limbal tissues and stem cells. This is mainly owing to its
biological products, including anti-inflammatory abilities. These properties
have enhanced the success rate of LSC transplantation to a large extent.
Besides, the beneficial properties of the amniotic membrane have increased
their use in clinical trials to expand its application in other treatments.
Therefore, these factors are expected to widen the scope and growth of the
amniotic membrane market.
The sterilized, freeze-dried amniotic membrane,
also known as lyophilization, is a preservative method that employs the
freezing process to preserve the amniotic membrane for a longer duration. A
lyophilized amniotic membrane is considered an ideal option for ocular surface
reconstruction. The freezing method reduces storage costs, enhancing its use in
various treatments. The amniotic membrane
market is segmented into end-users, type, and application. The type section
is bifurcated into cryopreserved and lyophilization amniotic membranes.
The
major firms in the studied market include Organogenesis, Katena Products Inc,
Mimedx, Bio Tissue Inc, Labtician Ophthalmics Inc, and Amniox Medical Inc.
Organogenesis is a regenerative medicine company
focused on developing, manufacturing, and commercialization of solutions for
advanced wound care and surgical medicine. The company provides products to
various healthcare consumers, including hospitals, wound care centers,
government facilities, and physician offices. Additionally, its product line increases
regenerative medicine products in various stages and sports medicine products.
The company is headquartered in Canton, Massachusetts, the United States.
Organogenesis, a leading regenerative medicine
company, announced gaining approval from FDA for ReNu, a cryopreserved amniotic
suspension allograft, to manage symptoms related to knee osteoarthritis.
Key deliverables of the report:
●
Market CAGR during the forecasting years 2022-2028
●
Detailed data highlighting key insights, industry components, and
market strategies
● Comprehensive information and estimation of the amniotic membrane
market revenue growth in North America and its influence on the parent market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
● A wide-ranging study of factors that will challenge the NA
amniotic membrane market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
1. NORTH
AMERICA AMNIOTIC MEMBRANE MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON AMNIOTIC MEMBRANE MARKET
2.2. KEY
INSIGHTS
2.2.1. POTENTIAL
AMNIOTIC MEMBRANE USE TO TREAT LUNG DAMAGES DUE TO COVID-19
2.2.2. SIGNIFICANT
INVESTMENTS IN RESEARCH AND DEVELOPMENT ACTIVITIES
2.2.3. GROWING
HEALTHCARE SECTOR IN THE ASIA-PACIFIC REGION
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. ACQUISITIONS
2.6.2. PRODUCT
DEVELOPMENTS
2.6.3. AGREEMENTS
2.7. MARKET
DRIVERS
2.7.1. RISING
AWARENESS OF WOUND CARE TREATMENT
2.7.2. GROWING
RESEARCH ON STEM CELL BIOLOGY AND REGENERATIVE MEDICINE
2.7.3. INCIDENTS
OF BURN INJURIES AND TRAUMATIC WOUNDS
2.8. MARKET
CHALLENGE
2.8.1. LIMITATIONS
RELATED TO AMNIOTIC MEMBRANE USE
2.9. MARKET
OPPORTUNITIES
2.9.1. POTENTIAL
USE IN TISSUE ENGINEERING APPLICATIONS.
2.9.2. GROWTH
OF OPHTHALMOLOGY SEGMENT
3. NORTH
AMERICA AMNIOTIC MEMBRANE MARKET OUTLOOK - BY TYPE
3.1. CRYOPRESERVED
AMNIOTIC MEMBRANE
3.2. LYOPHILIZATION
AMNIOTIC MEMBRANE
4. NORTH
AMERICA AMNIOTIC MEMBRANE MARKET OUTLOOK - BY APPLICATION
4.1. SURGICAL
WOUNDS
4.2. OPHTHALMOLOGY
4.3. OTHER
APPLICATIONS
5. NORTH
AMERICA AMNIOTIC MEMBRANE MARKET OUTLOOK - BY END-USERS
5.1. HOSPITALS
5.2. AMBULATORY
SURGICAL CENTERS
5.3. SPECIALIZED
CLINICS
5.4. RESEARCH
CENTERS & LABORATORIES
6. NORTH
AMERICA AMNIOTIC MEMBRANE MARKET – REGIONAL OUTLOOK
6.1. UNITED
STATES
6.2. CANADA
7. COMPETITIVE
LANDSCAPE
7.1. AMINO
TECHNOLOGY LLC
7.2. KATENA
PRODUCTS INC
7.3. MIMEDX
7.4. BIO
TISSUE INC
7.5. SURGILOGIX
LLC
7.6. AMNIOX
MEDICAL INC
7.7. SURGENIX
LLC
7.8. LABTICIAN
OPHTHALMICS INC
7.9. HUMAN
REGENERATIVE TECHNOLOGIES
7.10. INTEGRA
LIFESCIENCE CORP
7.11. SMITH
AND NEPHEW PLC
7.12. ORGANOGENESIS
7.13. CELULARITY
INC
7.14. SKY
BIOLOGICS LLC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: LIST OF
ACQUISITIONS
TABLE 4: LIST OF
PRODUCT DEVELOPMENTS
TABLE 5: LIST OF
PARTNERSHIPS & AGREEMENTS
TABLE 6: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, BY END-USERS, 2022-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
FIGURE 1: MARKET ATTRACTIVENESS
INDEX
FIGURE 2: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, TYPE OUTLOOK, 2021 & 2028 (IN %)
FIGURE 3: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, BY CRYOPRESERVED AMNIOTIC MEMBRANE, 2022-2028 (IN $
MILLION)
FIGURE 4: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, BY LYOPHILIZATION AMNIOTIC MEMBRANE, 2022-2028 (IN $
MILLION)
FIGURE 5: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, APPLICATION OUTLOOK, 2021 & 2028 (IN %)
FIGURE 6: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, BY SURGICAL WOUNDS, 2022-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, BY OPHTHALMOLOGY, 2022-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA
AMNIOTIC MEMBRANE MARKET, END-USERS OUTLOOK, 2021 & 2028 (IN %)
FIGURE 10: NORTH
AMERICA AMNIOTIC MEMBRANE MARKET, BY OPHTHALMOLOGY, 2022-2028 (IN $ MILLION)
FIGURE 11: NORTH
AMERICA AMNIOTIC MEMBRANE MARKET, BY AMBULATORY SURGICAL CENTERS, 2022-2028 (IN
$ MILLION)
FIGURE 12: NORTH
AMERICA AMNIOTIC MEMBRANE MARKET, BY SPECIALIZED CLINICS, 2022-2028 (IN $ MILLION)
FIGURE 13: NORTH
AMERICA AMNIOTIC MEMBRANE MARKET, BY RESEARCH CENTER & LABORATORIES,
2022-2028 (IN $ MILION)
FIGURE 14: NORTH
AMERICA AMNIOTIC MEMBRANE MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 15: UNITED STATES
AMNIOTIC MEMBRANE MARKET 2022-2028 (IN $ MILLION)
FIGURE 16: CANADA
AMNIOTIC MEMBRANE MARKET 2022-2028 (IN $ MILLION)